RT Journal Article
SR Electronic
T1 First-in-human phase Ib trial of M9241 (NHS-IL12) plus avelumab in patients with advanced solid tumors, including dose expansion in patients with advanced urothelial carcinoma
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e005813
DO 10.1136/jitc-2022-005813
VO 11
IS 5
A1 Strauss, Julius
A1 Deville, Jean-Laurent
A1 Sznol, Mario
A1 Ravaud, Alain
A1 Maruzzo, Marco
A1 Pachynski, Russell K
A1 Gourdin, Theodore S
A1 Maio, Michele
A1 Dirix, Luc
A1 Schlom, Jeffrey
A1 Donahue, Renee N
A1 Tsai, Yo-Ting
A1 Wang, XiaoZhe
A1 Vugmeyster, Yulia
A1 Beier, Frank
A1 Seebeck, Joerg
A1 Schroeder, Andreas
A1 Chennoufi, Sarah
A1 Gulley, James L
YR 2023
UL http://jitc.bmj.com/content/11/5/e005813.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.